Stifel Nicolaus Raises Deciphera Pharmaceuticals (NASDAQ:DCPH) Price Target to $23.00
Deciphera Pharmaceuticals (NASDAQ:DCPH – Free Report) had its price objective lifted by Stifel Nicolaus from $22.00 to $23.00 in a research report report published on Wednesday, Benzinga reports. Stifel Nicolaus currently has a buy rating on the stock. Other equities research analysts have also issued research reports about the stock. Piper Sandler raised shares of […]
More Stories
Financial Contrast: Taysha Gene Therapies (NASDAQ:TSHA) versus AIM ImmunoTech (NYSE:AIM)
Taysha Gene Therapies (NASDAQ:TSHA – Get Free Report) and AIM ImmunoTech (NYSE:AIM – Get Free Report) are both small-cap medical...
GGL Resources (CVE:GGL) Trading 33.3% Higher – Should You Buy?
GGL Resources Corp. (CVE:GGL – Get Free Report) shares were up 33.3% on Saturday . The stock traded as high...
Eagle Point Credit Company Inc. (ECCC) to Issue Dividend of $0.14 on January 31st
Eagle Point Credit Company Inc. (NYSE:ECCC – Get Free Report) declared a dividend on Saturday, January 11th,investing.com reports. Investors of...
GreenPower Motor (CVE:GPV) Trading Up 38.1% – Here’s What Happened
GreenPower Motor Company Inc. (CVE:GPV – Get Free Report) shares traded up 38.1% during trading on Saturday . The company...
Eagle Point Credit Company Inc. Announces Dividend of $0.14 (NYSE:ECCC)
Eagle Point Credit Company Inc. (NYSE:ECCC – Get Free Report) declared a dividend on Saturday, January 11th,investing.com reports. Investors of...
Oracle Power (LON:ORCP) Shares Down 14.3% – What’s Next?
Oracle Power plc (LON:ORCP – Get Free Report) shares dropped 14.3% during mid-day trading on Saturday . The company traded...